BERNARDINO GHETTI, M.D.
Medical Practice at Barnhill Dr, Indianapolis, IN
License number
Indiana 01027412A
Category
Medical Practice
Type
Clinical Pathology/Laboratory Medicine
Address
Address
635 Barnhill Dr, Indianapolis, IN 46202
Phone
(317) 274-4806
Personal information
See more information about BERNARDINO GHETTI at radaris.comName
Address
Phone
1124 Frederick Dr S, Indianapolis, IN 46260
1124 Frederick Dr S, Indianapolis, IN 46260
Organization information
See more information about BERNARDINO GHETTI at bizstanding.comBernardino Ghetti MD
635 Barnhill Dr, Indianapolis, IN 46202
Phone:
(317) 274-4806 (Phone)
Description:
There are 37 doctors at this site. Surgery is not performed at this site.
Bernardino N. Ghetti
Professional information
Distinguished Professor At Indiana University School Of Medicine
Position:
professor at Indiana University School of Medicine
Location:
Indianapolis, Indiana Area
Industry:
Research
Work:
Indiana University School of Medicine
-
professor
Bernardino N Ghetti, Indianapolis IN
Specialties:
Pathologist
Address:
635 Barnhill Dr, Indianapolis, IN 46202
Education:
University of Pisa, Faculty of Medicine and Surgery - Doctor of Medicine
Montefiore Medical Center - Fellowship - Neuropathology (Pathology)
Montefiore Medical Center - Residency - Neuropathology (Pathology)
Montefiore Medical Center - Residency - Pathology
Montefiore Medical Center - Fellowship - Neuropathology (Pathology)
Montefiore Medical Center - Residency - Neuropathology (Pathology)
Montefiore Medical Center - Residency - Pathology
Board certifications:
American Board of Pathology Sub-certificate in Neuropathology (Pathology)
Bernardino N Ghetti, Indianapolis IN
Specialties:
Pathology, Neuropathology, Clinical Pathology/Laboratory Medicine
Work:
Indiana University
635 Barnhill Dr, Indianapolis, IN 46266
635 Barnhill Dr, Indianapolis, IN 46266
Education:
Universita Di Pisa (1966)
Dr. Bernardino Ghetti, Indianapolis IN - MD (Doctor of Medicine)
Specialties:
Neuropathology
Address:
IU Health Pathology Laboratory
350 W 11Th St SUITE 4010, Indianapolis 46202
(317) 491-6000 (Phone)
350 W 11Th St SUITE 4010, Indianapolis 46202
(317) 491-6000 (Phone)
Certifications:
Neuropathology, 1982
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Universita Di Pisa, Facolta Di Medicina E Chirurgia
Graduated: 1966
Santa Chiara Hospital
Einstein College Med
Graduated: 1975
Graduated: 1973
Universita Di Pisa, Facolta Di Medicina E Chirurgia
Graduated: 1966
Santa Chiara Hospital
Einstein College Med
Graduated: 1975
Graduated: 1973
Ferritin Light Subunit Variant-Encoding Nucleic Acids, Polypeptides, Transgenic Animals Comprising The Same, Antibodies Thereto, And Methods Of Use Thereof
US Patent:
7332643, Feb 19, 2008
Filed:
Oct 14, 2003
Appl. No.:
10/684742
Inventors:
Bernardino Ghetti - Indianapolis IN, US
Ruben Vidal - Indianapolis IN, US
Ruben Vidal - Indianapolis IN, US
Assignee:
Indiana University & Technology Corp. - Indianapolis IN
International Classification:
G01N 33/00, A01K 67/00, A01K 67/027, C07H 21/04, A01N 63/00
US Classification:
800 3, 800 13, 800 18, 536 235, 536 241, 424 9321
Abstract:
Nucleic acids encoding a novel ferritin light chain variant, a ferritin light chain variant polypeptide, ferritin light chain variant polypeptide-specific antibodies, and methods of use thereof are provided herein. Also provided are methods to screen and identify agents capable of modulating the activity of the ferritin light chain variant.
Transgenic Mouse Expressing App770-V717F
US Patent:
6184435, Feb 6, 2001
Filed:
Jun 7, 1995
Appl. No.:
8/475176
Inventors:
Merrill D. Benson - Indianapolis IN
Jill Murrell - Indianapolis IN
Martin Farlow - Indianapolis IN
Bernardino Ghetti - Indianapolis IN
Jill Murrell - Indianapolis IN
Martin Farlow - Indianapolis IN
Bernardino Ghetti - Indianapolis IN
Assignee:
Advanced Research and Technology Institute - Bloomington IN
International Classification:
A01K 67027, A01K 67033, G01N 3300
US Classification:
800 18
Abstract:
Methods for screening for risk of Alzheimer's disease involve assaying for a guanine to thymine substitution at position 1924 of the gene encoding the human amyloid precursor protein. Also described are transgenic non-human mammals, especially transgenic mice, harboring an expressable gene sequence encoding human amyloid precursor protein having a phenyalanine for valine amino acid substitution in the transmembrane domain of the amyloid precursor protein.
Method For Screening For Alzheimer's Disease
US Patent:
5879883, Mar 9, 1999
Filed:
May 3, 1995
Appl. No.:
8/434018
Inventors:
Merrill D. Benson - Indianapolis IN
Jill Murrell - Indianapolis IN
Martin Farlow - Indianapolis IN
Bernardino Ghetti - Indianapolis IN
Jill Murrell - Indianapolis IN
Martin Farlow - Indianapolis IN
Bernardino Ghetti - Indianapolis IN
Assignee:
Indiana University Foundation - Bloomington IN
International Classification:
C12Q 168, C12N 1511, C07H 2104
US Classification:
435 6
Abstract:
Method for screening for risk of Alzheimer's disease involve assaying for a guanine to thymine substitution at position 1924 of the gene encoding the human amyloid precursor protein. Also described are transgenic mammals harboring an expressable gene sequence encoding human amyloid precursor protein having a phenyanine for valine amino acid substitution in the transmembrane domain of the amyloid precursor protein.
Methods And Compositions For Diagnosing Tauopathies
US Patent:
2002001, Feb 14, 2002
Filed:
Nov 29, 2000
Appl. No.:
09/726771
Inventors:
Bernardino Ghetti - Indianapolis IN, US
Maria Spillantini - Cambridge, GB
Jill Murrell - Avon IN, US
Michel Goedert - Cambridge, GB
Martin Farlow - Indianapolis IN, US
Aaron Klug - Cambridge, GB
Maria Spillantini - Cambridge, GB
Jill Murrell - Avon IN, US
Michel Goedert - Cambridge, GB
Martin Farlow - Indianapolis IN, US
Aaron Klug - Cambridge, GB
Assignee:
Advanced Research and Technology
International Classification:
C12Q001/68, G01N033/567, G01N033/53, G01N033/537, G01N033/543
US Classification:
435/006000, 435/007210, 435/007920
Abstract:
The present invention relates generally to methods and compositions for the diagnosis, modeling and treatment of tau-related pathologies. In particular, the present invention shows that mutations in the tau gene lead to neurofibrillary tangle formation. More specifically gene mutations are described that lead to alterations in ratios of tau isoforms are shown to lead to the formation of abnormal tau filaments.